Patient | Age, sex (years) | Disease | Uveitis | MIF concentrations (ng/ml) | |||||
---|---|---|---|---|---|---|---|---|---|
Anatomical type | Grade | ||||||||
1 | 26, M | Behçet's diease | panuveitis | 4 | 10.6 | ||||
2 | 27, M | VKH disease | panuveitis | 3 | 2 | ||||
3 | 47, F | VKH disease | panuveitis | 2 | 4.2 | ||||
4 | 52, F | VKH disease | panuveitis | 2 | 2.2 | ||||
5 | 41, M | Sarcoidosis | panuveitis | 2 | 1.9 | ||||
6 | 60, F | Sarcoidosis | panuveitis | 3 | 1.8 | ||||
7 | 67, M | Acute anterior uveitis | anterior uveitis | 4 | 1.6 | ||||
8 | 53, F | HTLV-I uveitis | panuveitis | 2 | 4.1 | ||||
9 | 55, F | ARNS | panuveitis | 4 | 4.1 | ||||
10 | 47, M | ARNS | panuveitis | 4 | 9.6 | ||||
11 | 45, M | Toxocariasis | panuveitis | 0 | 2.2 | ||||
12 | 58, M | Toxocariasis | panuveitis | 0 | 3.6 | ||||
4.0 (3.0) |
↵p<0.005, compared with controls (Mann-Whitney U test).
VKH = Vogt-Koyanagi-Harada; HTLV-I = human T cell lymphotropic virus type I; ARNS = acute retinal necrosis syndrome.